Zachary Kanter

Zachary Kanter serves as Chief Business Officer at Roivant Sciences since January 2018, driving advancements in bio, health, and tech through new venture incubation, strategic partnerships, and capital development. At VantAI, Kanter leads business development for an AI/ML drug discovery platform, collaborating with major biopharma companies. Previous roles include Strategic Finance & Operations at Datavant and Operations Team Leader at Chai Lifeline, demonstrating a commitment to health technology and non-profit sectors. Kanter's academic background includes a Master's degree from London Business School and an EMBA-Global Asia from Columbia Business School, among others.